Skip to main content
. 2020 Jul 1;13(7):32–35.

TABLE 2.

Treatment results shown by subgroup in the botulinum toxin A therapy group (N=26)

SUBGROUP SCORAD BEFORE (MEAN±SD) SCORAD AFTER (MEAN±SD) P-VALUE (AFTER VS. BEFORE)
All patients 50±21 11±10 <0.001
Sex
Males 52±21 14±12 <0.001
Females 50±21 9±6 <0.001
Age
<17 years 47±19 10±7 <0.001
≥17 years 54±23 12±12 <0.001
Duration
<7 years 55±21 11±8 <0.001
≥7 years 47±20 11±11 <0.001
Onset
<1.5 years 53±19 14±11 <0.001
≥1.5 years 48±22 8±7 <0.001
Baseline disease severity
Mild (SCORAD<25 points) 20±4 7±5 0.004
Moderate (SCORAD 25–50 points) 38±8 19±6 <0.001
Severe (SCORAD>50 points) 69±11 14±12 <0.001